Gut microbiota‐derived synbiotic formula (SIM01) as a novel

Full article: A comprehensive perspective on the interaction between gut microbiota and COVID-19 vaccines

Full article: A comprehensive perspective on the interaction between gut microbiota and COVID-19 vaccines

Probiotics for immunomodulation in prevention against respiratory viral infections with special emphasis on COVID-19

PDF) A novel gut microbiota‐derived synbiotic formula (SIM01) as an adjuvant therapy for COVID‐19: An open‐label pilot study

PDF) Effects of Gut Microbiome Modulation on Reducing Adverse Health Outcomes among Elderly and Diabetes Patients during the COVID-19 Pandemic: A Randomised, Double-Blind, Placebo-Controlled Trial (IMPACT Study)

Synbiotic formula shows promise in reducing long COVID symptoms

Microbiota I-Center (MagIC) (香港微生物菌群創新中心) on LinkedIn: #covid #gut # microbiota #microbiome #sim01 #cuhk #cumedicine #covid19

Nutrients, Free Full-Text

Characterization of the Intestinal Microbiome in Healthy Adults over Sars-Cov-2 Vaccination

Long COVID: major findings, mechanisms and recommendations

A synbiotic preparation (SIM01) for post-acute COVID-19 syndrome in Hong Kong (RECOVERY): a randomised, double-blind, placebo-controlled trial - The Lancet Infectious Diseases

Gut microbiota in COVID-19: key microbial changes, potential mechanisms and clinical applications

Characterization of the Intestinal Microbiome in Healthy Adults over Sars-Cov-2 Vaccination